Catherine Boileau
Responsable de l'équipe, Cardiovascular structural diseases
Institution:
USPC - SET - SVS
Summary
Published articles Show More
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
...Published in Nature Genetics
Marfan Sartan: a randomized, double-blind, placebo-controlled trial
...
AIMS: To evaluate the benefit of adding Losartan to baseline therapy in patients with Marfan syndrome (MFS). METHODS AND RESULTS: A double-blind, randomized, multi-centre, placebo-controlled, add on trial comparing Losartan (50 mg when \textless50 kg, 100 mg otherwise) vs. placebo in patients with MFS according to Ghent criteria, age \textgreater10...
Heterozygous RTEL1 mutations areassociated with familial pulmonary fibrosis
...
Pulmonary fibrosis is a fatal disease with progressive loss of respiratory function. Defectivetelomere maintenance leading to telomere shortening is a cause of pulmonary fibrosis, as mutations in thetelomerase component genes TERT (reverse transcriptase) and TERC (RNA component) are found in 15% offamilial pulmonary fibrosis (FPF) cases. However, s...
Experience
Responsable de l'équipe
Université Paris Diderot
Cardiovascular structural diseases; U1148, Laboratory for Vascular Translational Science; UFR de Médecine
